European Heart JournalGreat Debate: Surgical Aortic Valve Replacement is First Choice for Aortic Stenosis in Patients with a Life Expectancy Beyond 5 Years

A European Heart Journal debate weighs whether surgical aortic valve replacement should remain first choice for aortic stenosis patients with life expectancy beyond 5 years, given limited longer-term TAVI durability data. The graphical abstract frames the article as PROs and CONs of SAVR versus TAVI.

Clinical Considerations

• Current debate centers on 5-year equivalence versus uncertainty about outcomes beyond that horizon.
• TAVI concerns include pacemaker requirement, paravalvular regurgitation, and unresolved durability questions.
• SAVR may retain relevance for lower-risk patients with longer projected survival and operable anatomy.
• The article reinforces decision-making based on anatomy, age, comorbidity, durability, and patient priorities.

Practice Applications

• Interpret TAVI and SAVR comparisons through expected survival, not age alone.
• Discuss durability uncertainty when counseling patients likely to live beyond 5 years.
• Recognize the graphical abstract as useful for quick clinician engagement, pending reuse permissions.
• Avoid treating debate commentary as new randomized evidence.